Scholarlink

Background <p>Postsurgical gastroparesis syndrome (PGS) is a common complication after distal gastrectomy that impairs quality of life and increases healthcare costs, yet its risk factors and long-term prognostic impact remain unclear.</p> Objective <p>To identify PGS risk factors after radical distal gastrectomy, develop and validate a model, and assess its association with long-term survival.</p> Methods <p>We retrospectively analyzed patients undergoing radical distal gastrectomy at Qilu Hospital of Shandong University between January 2012 and December 2023. Patients were assigned to training and validation cohorts by surgery date. Logistic regression was used to identify independent risk factors and develop a PGS prediction nomogram. Propensity score overlap weighting (PSOW) was applied to reduce confounding, and the prognostic impact of PGS was assessed using weighted Kaplan–Meier analysis, log-rank tests, and Cox regression.</p> Results <p>A total of 2490 patients were included (training cohort: 1934 [77.7%]; validation cohort: 556 [22.3%]), among whom 238 developed PGS (training cohort: 187). Independent risk factors included prolonged operative time (OR = 1.01), intellectual work (OR = 2.02), well-controlled diabetes (OR = 3.10), poorly controlled diabetes (OR = 4.95), history of constipation (OR = 2.46), preoperative pyloric obstruction (OR = 3.77), perioperative psychiatric symptoms (OR = 4.60), and Billroth II (OR = 3.07) or Roux-en-Y anastomosis (OR = 6.29). Protective factors were higher preoperative plasma albumin (OR = 0.96) and laparoscopic surgery (OR = 0.47) (all <i>p</i> &lt; 0.05). The nomogram showed good discrimination and calibration, with AUCs of 0.81 for the training cohort, 0.81 for internal validation, and 0.82 for temporal validation. Patients with PGS exhibited significantly worse survival outcomes, and PGS was independently associated with poorer survival in the overlap-weighted analysis (HR 1.41, 95% CI 1.12–1.79, <i>p</i> = 0.004).</p> Conclusions <p>The nomogram prediction model based on the risk factors for PGS occurrence has potential value in predicting the onset of PGS. PGS is significantly associated with the prognosis of patients after radical surgery for distal gastric cancer.</p> Clinical trial registration <p>This study was registered at the Chinese Clinical Trial Registry (Registration No.: ChiCTR2300069234).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Predictive nomogram for postsurgical gastroparesis syndrome and survival outcomes following distal gastrectomy: an in-depth analysis

  • 期刊论文

  • 发表日期：

    2026年2月26日

查看全文
  • Chuanqi Chen,
  • Jinghao Guo,
  • Meng Wei,
  • Yongqi Yan,
  • Menghui Wang,
  • Honglei Wang,
  • Zepeng Yan,
  • Yangjia Li,
  • Yihang Xu,
  • Zhibo Yan,
  • Wenbin Yu

摘要

Background

Postsurgical gastroparesis syndrome (PGS) is a common complication after distal gastrectomy that impairs quality of life and increases healthcare costs, yet its risk factors and long-term prognostic impact remain unclear.

Objective

To identify PGS risk factors after radical distal gastrectomy, develop and validate a model, and assess its association with long-term survival.

Methods

We retrospectively analyzed patients undergoing radical distal gastrectomy at Qilu Hospital of Shandong University between January 2012 and December 2023. Patients were assigned to training and validation cohorts by surgery date. Logistic regression was used to identify independent risk factors and develop a PGS prediction nomogram. Propensity score overlap weighting (PSOW) was applied to reduce confounding, and the prognostic impact of PGS was assessed using weighted Kaplan–Meier analysis, log-rank tests, and Cox regression.

Results

A total of 2490 patients were included (training cohort: 1934 [77.7%]; validation cohort: 556 [22.3%]), among whom 238 developed PGS (training cohort: 187). Independent risk factors included prolonged operative time (OR = 1.01), intellectual work (OR = 2.02), well-controlled diabetes (OR = 3.10), poorly controlled diabetes (OR = 4.95), history of constipation (OR = 2.46), preoperative pyloric obstruction (OR = 3.77), perioperative psychiatric symptoms (OR = 4.60), and Billroth II (OR = 3.07) or Roux-en-Y anastomosis (OR = 6.29). Protective factors were higher preoperative plasma albumin (OR = 0.96) and laparoscopic surgery (OR = 0.47) (all p < 0.05). The nomogram showed good discrimination and calibration, with AUCs of 0.81 for the training cohort, 0.81 for internal validation, and 0.82 for temporal validation. Patients with PGS exhibited significantly worse survival outcomes, and PGS was independently associated with poorer survival in the overlap-weighted analysis (HR 1.41, 95% CI 1.12–1.79, p = 0.004).

Conclusions

The nomogram prediction model based on the risk factors for PGS occurrence has potential value in predicting the onset of PGS. PGS is significantly associated with the prognosis of patients after radical surgery for distal gastric cancer.

Clinical trial registration

This study was registered at the Chinese Clinical Trial Registry (Registration No.: ChiCTR2300069234).